Skip to main content
. 2017 Feb 20;13(4):1285–1294. doi: 10.3892/etm.2017.4134

Figure 1.

Figure 1.

Effect of sunitinib on the proliferation in PC-3 and LNCaP cells. Following 5, 10 or 20 µmol/l sunitinib treatment in PC-3 and LNCaP cells for 24 h, cell viability was measured using a Cell Counting Kit-8 kit assay. Sunitinib inhibited the proliferation of (A) PC-3 and (B) LNCaP cells in a dose-dependent manner. Data are presented as mean ± standard deviation (n=4). *P<0.05 and **P<0.01 vs. Con. Con, control.